Article Sidebar
Views pdf: 66
QUALITY OF LIFE AND RELATED FACTORS IN HOSPITALIZED PATIENTS WITH ULCERATIVE COLITIS
Main Article Content
Abstract
Objective: To describe the quality of life and some related factors in patients with ulcerative colitis. Subjects and methods: A cross-sectional description of 38 patients with ulcerative colitis treated as inpatients at the Center for Gastroenterology and Hepatology, Bach Mai Hospital, and the Department of General Internal Medicine, Hanoi Medical University Hospital from August 2019 to August 2020. All patients were interviewed with the IBDQ-32 quality of life questionnaire. Results: Patients were mainly in the over 40 age group with a rate of 65.8%, females were more than males with a ratio of approximately 1.3/1. The average IBDQ-32 score was 120.63±24.52, of which, the intestinal symptom group (B) was 36.73±8.68; the general health group (S) was 15.21±4.88; the social function group (SF) was 19.73±6.22; the emotional group (E) was 48.94±9.62. There was a correlation between the quality of life score and the number of bowel movements per day, steroid treatment, in which, the number of bowel movements over 6 times and steroid treatment had a lower quality of life (p<0.05). The quality of life score of patients at the time of admission was inversely correlated with the severity according to the Mayo score, the number of symptoms of the patient, and the number of bowel movements per day with p<0.05. Conclusion: Quality of life in both males and females is the same, lowest in the 40-49 age group, severe disease level, and is inversely correlated with the number of bowel movements, the number of symptoms of the patient, and the Mayo score.
Article Details
Keywords
Ulcerative colitis, quality of life, IBDQ-32
References
2. Masachs M, Casellas F, Malagelada J. Spanish translation, adaptation, and validation of the 32-item questionnaire on quality of life for inflammatory bowel disease (IBDQ-32). Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva. 2007;99(9):511-519.
3. Dubinsky M, Rice A, Yarlas A, et al. Systematic Literature Review: Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health Indicators. Inflamm Bowel Dis. 2024;30(11):2115-2126. doi:10.1093/ibd/izad282.
4. Zavala-Solares MR, Salazar-Salas L, Yamamoto-Furusho JK. Validity and reliability of the health-related questionnaire IBDQ-32 in Mexican patients with inflammatory bowel disease. Gastroenterol Hepatol. 2021;44(10):711-718. doi:10.1016/j.gastrohep.2021.03.002.
5. van der Eijk I, Stockbrügger R, Russel M. Influence of quality of care on quality of life in inflammatory bowel disease (IBD): literature review and studies planned. European journal of internal medicine. 2000;11(4):228-234.
6. Ngô Gia Mạnh. Nghiên cứu ứng dụng thang điểm mayo trong viêm loét đại trực tràng chảy máu. Hà Nội, Trường Đại học Y Hà Nội; 2018.
7. Kornbluth A, Sachar DB, Gastroenterology PPCotACo. Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee. Official journal of the American College of Gastroenterology| ACG. 2010;105(3):501-523.
8. Panés J, Su C, Bushmakin AG, Cappelleri JC, Mamolo C, Healey P. Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes. BMC gastroenterology. 2015;15:1-10.
9. Sainsbury A, Heatley R. Psychosocial factors in the quality of life of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics. 2005;21(5):499-508.